Skip to content

Effect of Lotion of Myrtus communts and Phyllanthus emblica on the Androgenic Alopecia

Evaluation of the Effect of Topical Lotion of Myrtus communts and Phyllanthus emblica on the Androgenic Alopecia in Women: A Clinical Trial Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230808059082N1
Enrollment
120
Registered
2024-02-24
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia. Androgenic alopecia

Interventions

Intervention groups: 4 including group 1: Iranian traditional medicine lotion based on Mirtica, group 2: traditional medicine lotion based on Amla, group 3: herbal product lotion based on the combinat

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Females in the pre-menopausal period complaining of hair loss Patient consent to participate and fill out the informed consent form.

Exclusion criteria

Exclusion criteria: History of allergic response/hypersensitivity to any ingredients and pharmaceutical products. History of thyroid disorder, diabetes mellitus, polycystic ovary syndrome Subjects under medical treatment for hair problems, consuming drugs (such as minoxidil, finasteride, platelet rich plasma or Biotin) and laser therapy in the 2 months prior to the study Subjects under medical treatment for hair problems with 5 a-reductase inhibitors. Subjects under medical treatment with antiandrogenic agents (such as spironolactone, cimetidine and cyproterone acetate) in the 2 months prior to the study Subjects consuming systemic corticosteroid therapy for more than 14 days in the 2 months prior to the study Any active scalp disease in the 6 months prior to the study Any history of cancer or autoimmune diseases History of hair transplant Pregnancy or Brest - feeding History of serious acute illness in the 2 months prior to the study

Design outcomes

Primary

MeasureTime frame
Hair count (number of hairs in 0.7 cm2). Timepoint: Week 8, week 16. Method of measurement: Trichoscan method.;Hair density (number of hairs in cm2). Timepoint: Week 8, week 16. Method of measurement: Trichoscan method.;Hair diameter. Timepoint: Week 8, week 16. Method of measurement: Trichoscan method.;Ratio of anagen to telogen. Timepoint: week8, week16. Method of measurement: Trichoscan method.

Secondary

MeasureTime frame
Dandruff. Timepoint: Before and after study (week1, week16). Method of measurement: Patient view assessment (5 Likert).;Greasy hair. Timepoint: Before and after study (week1, week16). Method of measurement: Patient view assessment(5 Likert).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Maftoon

Tehran University of Medical Sciences

fmaftoon5@gmail.com+98 912 326 2644

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026